Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China · Delayed Price · Currency is CNY 6.28
-0.16 (-2.48%)
Jun 11, 2026, 3:00 PM CST
SHA:605199 Market Cap
SHA:605199 has a market cap or net worth of 2.58 billion as of June 11, 2026. Its market cap has decreased by -31.56% in one year.
Market Cap
2.58B
Enterprise Value
3.73B
Revenue
710.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.28
Market Cap Chart
Since July 10, 2020, SHA:605199's market cap has decreased from 2.99B to 2.58B, a decrease of -13.79%. That is a compound annual growth rate of -2.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 2.58B | -15.49% |
| Dec 31, 2025 | 3.05B | -52.17% |
| Dec 31, 2024 | 6.37B | 5.08% |
| Dec 29, 2023 | 6.07B | -5.37% |
| Dec 30, 2022 | 6.41B | -35.71% |
| Dec 31, 2021 | 9.97B | 3.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet AIM Pharm. | 2.96B |
| Anhui Sunhere Pharmaceutical Excipients | 2.91B |
| Baotou Dongbao Bio-Tech Co.,Ltd | 2.90B |
| Tuoxin Pharmaceutical Group | 2.85B |
| Honz Pharmaceutical | 2.84B |
| Jiangxi Synergy Pharmaceutical | 2.80B |
| Shandong Sinobioway Biomedicine | 2.66B |
| Guizhou Yibai Pharmaceutical | 2.63B |